<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267653</url>
  </required_header>
  <id_info>
    <org_study_id>17100915</org_study_id>
    <nct_id>NCT04267653</nct_id>
  </id_info>
  <brief_title>Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia</brief_title>
  <official_title>Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lactoferrin (Lf) is a mammalian cationic iron binding glycoprotein belonging to the
      transferrin family which was discovered 70 years ago, and isolated simultaneously from human
      and bovine milks in 1960. It is widely distributed in all biological fluids and is also
      expressed by immune cells, which release it under stimulation by pathogens
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">October 30, 2018</completion_date>
  <primary_completion_date type="Actual">January 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia.</measure>
    <time_frame>30 days</time_frame>
    <description>Complete blood count will be done before and after therapy to detect the effect of the therapy on serum hemoglobin(g/d)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia.</measure>
    <time_frame>30 days</time_frame>
    <description>Total serum iron(ug/d) will be done before and after therapy to detect effect of the therapy on total serum iron level (ug/d)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Iron Deficiency Anemia Treatment</condition>
  <arm_group>
    <arm_group_label>lactoferrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral bovine lactoferrin (bfl) 100 mg once daily on empty stomach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ferrous sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral ferrous sulfate 3-6 mg/kg of elemental iron/day in divided doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combined</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>combined therapy (both lactoferrin and ferrous sulfate)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactoferrin Bovine</intervention_name>
    <description>treatment for 30 days</description>
    <arm_group_label>combined</arm_group_label>
    <arm_group_label>lactoferrin</arm_group_label>
    <other_name>Pravotin sachet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferrous Sulfate</intervention_name>
    <description>treatment for 30 days</description>
    <arm_group_label>combined</arm_group_label>
    <arm_group_label>ferrous sulfate</arm_group_label>
    <other_name>ferrovit syrup</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:all patients with iron deficiency anemia from 2 to 15 years old

        -

        Exclusion Criteria:

          -  Anemia rather than iron deficiency anemia.

          -  Family history of blood disease.

          -  Patients with thalassemia trait.

          -  Patients with chronic illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Gaber Ahmed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AssuitU</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Gaber Ahmed</investigator_full_name>
    <investigator_title>pediatrician</investigator_title>
  </responsible_party>
  <keyword>Iron deficiency anemia</keyword>
  <keyword>Lactoferrin</keyword>
  <keyword>Ferrous sulfate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

